Regenesis Biomedical Inc.
Scottsdale, AZ
- UEI
- YA8GEVA8TKJ5
- CAGE
- 33AL3
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 5301 N Pima Rd, Scottsdale, AZ 85250, USA
- Website
- regenesismed.com
- Founded
- 1997
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $0 |
| FY2023 | $96,006 |
Contract vehicles
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Epimed International Inc. | Farmers Branch, TX | 339112 Surgical and Medical Instrument Manufacturing |
| Promedtek Inc. | Scottsdale, AZ | 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing |
| Biowave Corporation | Westport, CT | 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing |
| Hanger Clinic | San Antonio, TX | 339113 Surgical Appliance and Supplies Manufacturing |
| Covidien Sales AKA Superdimension | — | 339112 Surgical and Medical Instrument Manufacturing |
About the company
Regenesis Biomedical Inc. is a privately held medical technology company focused on developing and marketing noninvasive regenerative medicine products. They have developed and patented the Provant Therapy System, which is indicated for the palliative treatment of post-operative pain and edema. Regenesis Biomedical has been registered in the System for Award Management (SAM.gov) database to pursue federal contracting opportunities since 2004.
The federal contract awards reviewed show that Regenesis Biomedical Inc. has primarily provided the Department of Veterans Affairs (VA) with the Provant Therapy System and related rental services under delivery orders and purchase orders against the company's GSA Schedule 65-II-A contract for medical equipment and supplies. The awards are for supplying the Provant Therapy System devices themselves as well as rental/leasing agreements to allow VA medical facilities to temporarily access the technology. The contracts range from several thousand dollars for short-term rentals up to around $96,000 for an outright purchase of the systems. Several of the awards are designated for VA healthcare networks across different regions of the country. No set-asides for preferential contracting vehicles were used in the sample of contracts reviewed. Based on the descriptions, it appears Regenesis Biomedical acts as the prime contractor providing their proprietary Provant Therapy System through these federal procurement contracts and does not subcontract the work to other suppliers. The ability to streamline purchases of the firm's patented medical device through GSA Schedules seems to be the core federal contracting activity for Regenesis Biomedical Inc.
SBA capabilities narrative
Regenesis Biomedical Inc. is a small business based in Scottsdale AZ. It's patented, core technology is cell proliferation induction. The company is involved in R&D, manufacturing and marketing/sales.
Quick answers
Is Regenesis Biomedical Inc. registered in SAM.gov?
Yes. Regenesis Biomedical Inc.'s SAM.gov registration is active through August 18, 2027.
Which contract vehicles does Regenesis Biomedical Inc. hold?
Regenesis Biomedical Inc. holds a place on 1 federal contract vehicle: FSS-65-II-A.
How much has Regenesis Biomedical Inc. received in federal contracts?
Federal contracts obligated $96,006 to Regenesis Biomedical Inc. in fiscal years 2023 through 2027.
What is Regenesis Biomedical Inc.'s most recent federal award?
Regenesis Biomedical Inc.'s most recent federal contract award is Provant therapy system (36C25623F0357), from Veterans Integrated Service Network 16 (VHA), on September 29, 2023.
On GovTribe
See Regenesis Biomedical Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors